Covid-19 Impact on Infectious Disease Diagnostic Market, Global Research Reports 2020-2021

2 Global Infectious Disease Diagnostic Quarterly Market Size Analysis

• 2.1 Infectious Disease Diagnostic Business Impact Assessment - COVID-19
  • 2.1.1 Global Infectious Disease Diagnostic Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Infectious Disease Diagnostic Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Infectious Disease Diagnostic Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Infectious Disease Diagnostic Headquarters and Area Served
• 3.3 Date of Key Players Enter into Infectious Disease Diagnostic Market
• 3.4 Key Players Infectious Disease Diagnostic Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Infectious Disease Diagnostic Segments, By Type

• 4.1 Introduction
  • 1.4.1 Instruments
  • 1.4.2 Consumables
  • 1.4.3 Software and Services
• 4.2 By Type, Global Infectious Disease Diagnostic Market Size, 2019-2021

5 Impact of Covid-19 on Infectious Disease Diagnostic Segments, By Application

• 5.1 Overview
  • 5.5.1 Hepatitis B virus (HBV)
  • 5.5.2 Hepatitis C virus (HCV)
  • 5.5.3 Acquired Immunodeficiency Syndrome (AIDS)
  • 5.5.4 Tuberculosis (TB)
  • 5.5.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • 5.5.6 Human Papillomavirus (HPV) infection
  • 5.5.7 Others
• 5.2 By Application, Global Infectious Disease Diagnostic Market Size, 2019-2021
  • 5.2.1 By Application, Global Infectious Disease Diagnostic Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Roche
  • 7.1.1 Roche Business Overview
  • 7.1.2 Roche Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.1.3 Roche Infectious Disease Diagnostic Product Introduction
  • 7.1.4 Roche Response to COVID-19 and Related Developments
• 7.2 BioMrieux SA
  • 7.2.1 BioMrieux SA Business Overview
  • 7.2.2 BioMrieux SA Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.2.3 BioMrieux SA Infectious Disease Diagnostic Product Introduction
  • 7.2.4 BioMrieux SA Response to COVID-19 and Related Developments
• 7.3 Bio-Rad Laboratories
  • 7.3.1 Bio-Rad Laboratories Business Overview
  • 7.3.2 Bio-Rad Laboratories Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.3.3 Bio-Rad Laboratories Infectious Disease Diagnostic Product Introduction
  • 7.3.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
• 7.4 Danaher Corporation
  • 7.4.1 Danaher Corporation Business Overview
  • 7.4.2 Danaher Corporation Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.4.3 Danaher Corporation Infectious Disease Diagnostic Product Introduction
  • 7.4.4 Danaher Corporation Response to COVID-19 and Related Developments
• 7.5 Becton
  • 7.5.1 Becton Business Overview
  • 7.5.2 Becton Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.5.3 Becton Infectious Disease Diagnostic Product Introduction
  • 7.5.4 Becton Response to COVID-19 and Related Developments
• 7.6 Dickinson and Company
  • 7.6.1 Dickinson and Company Business Overview
  • 7.6.2 Dickinson and Company Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.6.3 Dickinson and Company Infectious Disease Diagnostic Product Introduction
  • 7.6.4 Dickinson and Company Response to COVID-19 and Related Developments
• 7.7 Cepheid
  • 7.7.1 Cepheid Business Overview
  • 7.7.2 Cepheid Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.7.3 Cepheid Infectious Disease Diagnostic Product Introduction
  • 7.7.4 Cepheid Response to COVID-19 and Related Developments
• 7.8 Abbott
  • 7.8.1 Abbott Business Overview
  • 7.8.2 Abbott Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.8.3 Abbott Infectious Disease Diagnostic Product Introduction
  • 7.8.4 Abbott Response to COVID-19 and Related Developments
• 7.9 DiaSorin.
  • 7.9.1 DiaSorin. Business Overview
  • 7.9.2 DiaSorin. Infectious Disease Diagnostic Quarterly Revenue, 2020
  • 7.9.3 DiaSorin. Infectious Disease Diagnostic Product Introduction
  • 7.9.4 DiaSorin. Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US